{"id":1080,"date":"2022-08-08T01:37:34","date_gmt":"2022-08-08T05:37:34","guid":{"rendered":"https:\/\/aafa.org\/?page_id=1080"},"modified":"2025-10-07T13:48:49","modified_gmt":"2025-10-07T17:48:49","slug":"epinephrine-stocking-in-schools","status":"publish","type":"page","link":"https:\/\/aafa.org\/advocacy\/key-issues\/access-to-medications\/epinephrine-stocking-in-schools\/","title":{"rendered":"Epinephrine in Schools and Public Places"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Advocacy T-Hero Section” module_class=”hero tert” _builder_version=”4.18.0″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_Advocacy.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” global_module=”2187″ saved_tabs=”all” locked=”off” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.17.4″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” global_colors_info=”{}”]<\/p>\n

Advocacy<\/h2>\n

[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_right” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”H2 + Intro Content” module_class=”secondary-intro” _builder_version=”4.22.2″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”28px” text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n

Epinephrine in Schools and Public Places<\/h2>\n

AAFA supports school policies that require access to life-saving medications to treat students and staff who experience severe allergic reactions.<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Body Content” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” global_colors_info=”{}”]<\/p>\n

States should implement policies that promote access, including supplying schools with easy-to-use epinephrine for emergencies, appropriately training school personnel, and addressing liability concerns for people who use this medication in good faith.<\/p>\n

Food allergies continue to be a growing problem, especially among young children. Approximately 20 million people in the United States have food allergies, 4 million of whom are children. These children spend much of their day in school, where they may be exposed to food allergens which can trigger a severe immune response, known as anaphylaxis<\/a>. This severe allergic reaction can be life-threatening if not treated promptly.<\/p>\n

AAFA urges state lawmakers to make the simple decision to save young lives. Schools should have access to undesignated, easy-to-use epinephrine and staff trained to administer the medication.<\/p>\n

[\/et_pb_text][et_pb_text disabled_on=”off|off|off” admin_label=”Tan Callout Box – Modernizing Epinephrine Stocking Laws” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ link_line_height=”1.7em” ul_line_height=”1.7em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” background_color=”#F5EDDF” custom_padding=”4%|4%|4%|4%|true|true” box_shadow_style=”preset2″ global_colors_info=”{}”]<\/p>\n

Modernizing Epinephrine Stocking Laws<\/strong><\/p>\n

Emergency treatment options for anaphylaxis are rapidly advancing, but state laws on medication stocking have not kept pace. In 2024, the Food and Drug Administration (FDA) approved the first epinephrine nasal spray and is currently reviewing an epinephrine sublingual film, with further innovations expected in the future. Most state laws specify only epinephrine auto-injectors, limiting schools\u2019 ability to access different treatment types. By broadening language to include all forms of epinephrine, states can ensure that schools are prepared for current and future medical innovations.<\/p>\n

AAFA has an advocacy toolkit to help you advocate for epinephrine stocking in your state. The \u201cModernizing Epinephrine Stocking Laws: An Advocacy Toolkit<\/a>\u201d \"Download includes:<\/p>\n